Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Conference Could Last Into Fall; AWP One Sticking Point

Executive Summary

The House/Senate Medicare negotiations could last well into the fall, a staffer to Senate Majority Leader Bill Frist (R-Tenn.) predicted July 1
Advertisement

Related Content

AWP Settlements Unlikely To Resolve Pricing Issue, State Fraud Chief Says
Medicare AWP Reform Would Cause Oncologists To Drop Patients, ASCO Says
AWP Settlements Unlikely To Resolve Pricing Issue, State Fraud Chief Says
Medicare AWP Reform Would Cause Oncologists To Drop Patients, ASCO Says
Medicare Rx: Conferees Bring Diverse Agendas To Final Negotiations
Medicare Rx: Conferees Bring Diverse Agendas To Final Negotiations
Senate Medicare Bill Directs GAO To Study International Price Controls
Medicare Bills Head To Conference: Senate Earns Broader Bipartisan Support
Medicare Bills Head To Conference: Senate Earns Broader Bipartisan Support
AWP Reform: House Bill Offers Choice Of “Average Sales Price” Or Bids
Advertisement
UsernamePublicRestriction

Register

PS042096

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel